U.S. Markets closed

2 Stocks Taking Cues for This Year's Bull Market

CORAL GABLES, FL / ACCESSWIRE / January 29, 2018 / Monday morning has seen two companies begin to trend higher than the Friday afternoon closing prices. Both Graphite Energy Corp. (OTC PINK: GRXXF) and Atossa Genetics Inc. (ATOS) are trading higher today as the bull market continues to head higher. The S&P is in its longest streak without a 3 percent pullback, near the longest run without even a 1 percent dip and has gone 99 days without as much as a 0.6 percent daily loss - by far a record.

Graphite Energy Corp. (OTC PINK: GRXXF) has announced that it will commence a drill program at its Lac Aux Bouleaux property in Canada. This was based on results from its exploration work that was recently completed. Based on the findings, the company saw that their samples show upward of 22.3% graphite carbon indications and an average of just over 10% in surface samples from the property. a total of 82 samples including seven field duplicates were collected from rock outcrops, mineralized areas and historical graphite pits.

For the month of January, shares of Graphite Energy has increased by as much as 37% as the graphite industry continues to see interest grow as a result of the boom in alternative energy sources to power things like cars and consumer electronics.

For More Information on Graphite Energy Corp. (GRXXF) Click Here

Shares of Atossa Genetics, Inc. (ATOS) have seen a jump in price over the last 2 trading days. Last week Maxim began to cover the company. Analysts rated the company a Buy with a price target of $2. During the first quarter of this year the company is looking to commence the Phase 2 Study of its topical Endoxifen to treat MBD at Stockholm South General Hospital in Sweden.

As a clinical-stage pharmaceutical company, Atossa is developing therapeutics and delivery methods to treat breast cancer and other breast conditions. In a recent shareholder update, the company's President and CEO, Dr. Steve C. Quay stated, "Over the past two years, we have transformed Atossa into a pure play pharmaceutical company focused on the development of novel therapeutics and delivery methods aimed at both treating breast cancer as well as preventing breast cancer. We now have a remarkable opportunity to transform the field of breast cancer and substantially reduce the incidence of this deadly disease."

For More Information on Atossa Genetics, Inc. (ATOS) Click Here

About BlueSkyInvestor.com

BlueSkyInvestor.com is owned by, BEST MEDIA PUBLISHING, LLC (BMP) an affiliate of (BMP) JSG Communications, LLC has been compensated $400,000.00 by a non affiliate 3rd party Hilton Capital Inc. & $100,000.00 by Graphite Energy Corp. beginning January 16, 2018 and ending February 16, 2017 to publicly disseminate information about Graphite Energy Corp. We may buy or sell additional shares of Graphite Energy Corp in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares. Please read our full Disclaimer Here.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither BSI nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit BlueSkyInvestor.com

NO WARRANTY

BSI the Author, and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise, arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

Contact

News@BlueSkyInvestor.com

SOURCE: BlueSkyInvestor.com